Lv1
20 积分 2021-05-13 加入
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
3个月前
已完结
FDA analyses of survival in older adults with metastatic non–small cell lung cancer in controlled trials of PD-1/PD-L1 blocking antibodies
3个月前
已完结
Challenges and opportunities in rare cancer research in China
4个月前
已完结
皖公网安备34019202002308
